D. Brisgand

Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.

J. Soria, J. Pujol, J. Douillard, 2001, The oncologist.

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

J. Soria, T. le Chevalier, D. Brisgand, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

P Chomy, J L Pujol, J. Pujol, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas.

F. Eschwège, C. Hill, L. Cionini, 1997, International journal of radiation oncology, biology, physics.

Results of a european randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

F. Eschwège, C. Hill, L. Cionini, 1997 .

EUROPEAN ETANIDAZOLE PHASE III TRIAL (PROGRESS REPORT)

F. Eschwège, E. Malaise, H. Sancho-garnier, 1992 .